|
Index of reports
> Cases resulting in death (13)
Below is the selection of adverse event reports related to Altace (Ramipril) that includes cases resulting in death.
Adverse event in 68 year old male receiving Altace (Ramipril)
Reported by a physician from United States on 2007-07-27
Patient: 68 year old male
Adverse reactions / side effects: Syncope, Haemorrhage Intracranial, Fall
Adverse event resulted in: death
Suspect drug(s):
Norvasc
Indication: Hypertension
Warfarin Sodium
Dosage: daily dose:3.7mg
Start date: 2006-09-12
End date: 2007-06-18
Toprol-XL
Altace
Oxycodone HCL
Adverse event in receiving Altace (Ramipril)
Reported by a physician from United States on 2007-07-17
Patient:
Adverse reactions / side effects: Vomiting, Haemorrhage Intracranial, Hypotension, Mental Status Changes, Neurological Examination Abnormal, Fall, Dysarthria, Skin Laceration, Syncope
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Altace
Warfarin Sodium
Dosage: 3.7 mg, qd
Start date: 2006-09-12
Norvasc
Toprol-XL
Oxycodone HCL
Adverse event in 68 year old male receiving Altace (Ramipril)
Reported by a physician from United States on 2007-07-13
Patient: 68 year old male
Adverse reactions / side effects: Syncope, Skin Laceration, Haemorrhage Intracranial, Fall
Adverse event resulted in: death
Suspect drug(s):
Toprol-XL
Administration route: Oral
Warfarin Sodium
Start date: 2006-09-12
Norvasc
Altace
Oxycodone HCL
Adverse event in 68 year old male receiving Altace (Ramipril)
Reported by a individual with unspecified qualification on 2007-07-10
Patient: 68 year old male
Adverse reactions / side effects: Dysarthria, Vomiting, Skin Laceration, Syncope, Haemorrhage Intracranial, Fall
Adverse event resulted in: death
Suspect drug(s):
Oxycodone HCL
Dosage: unk mg, unk
Indication: Drug USE FOR Unknown Indication
Norvasc
Dosage: unk, unk
Indication: Drug USE FOR Unknown Indication
Toprol-XL
Dosage: unk, unk
Indication: Drug USE FOR Unknown Indication
Altace
Dosage: unk, unk
Indication: Drug USE FOR Unknown Indication
Warfarin Sodium
Dosage: 3.7 mg, daily
Indication: Drug USE FOR Unknown Indication
Start date: 2006-09-12
Adverse event in 68 year old male receiving Altace (Ramipril)
Reported by a individual with unspecified qualification on 2007-07-09
Patient: 68 year old male
Adverse reactions / side effects: Dysarthria, Vomiting, Skin Laceration, Syncope, Haemorrhage Intracranial, Fall
Adverse event resulted in: death
Suspect drug(s):
Oxycodone HCL
Dosage: unk mg, unk
Indication: Drug USE FOR Unknown Indication
Norvasc
Dosage: unk, unk
Indication: Drug USE FOR Unknown Indication
Toprol-XL
Dosage: unk, unk
Indication: Drug USE FOR Unknown Indication
Altace
Dosage: unk, unk
Indication: Drug USE FOR Unknown Indication
Warfarin Sodium
Dosage: 3.7 mg, daily
Indication: Drug USE FOR Unknown Indication
Start date: 2006-09-12
Adverse event in receiving Altace (Ramipril)
Reported by a consumer/non-health professional from Switzerland on 2007-06-26
Patient:
Adverse reactions / side effects: Blood Bilirubin Increased, Blood Alkaline Phosphatase Increased, Alanine Aminotransferase Increased, Bone Pain, General Physical Health Deterioration, Cholestasis, Cardiac Failure Acute, Aspartate Aminotransferase Increased, Pleural Effusion, Sinus Tachycardia
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Altace
Dosage: 1.25 mg, qd
Administration route: Oral
Start date: 2007-03-31
End date: 2007-04-13
Tazobac / 01173601 /
Dosage: 4.5 g, tid
Indication: Pneumonia Bacterial
Start date: 2007-03-26
End date: 2007-04-04
Augmentin / 00756801 /
Dosage: 1.2 g, bid
Indication: Pneumonia Bacterial
Start date: 2007-03-25
End date: 2007-03-26
Other drugs received by patient: Duragesic-100; Haldol Solutab; Seresta; Fragmin / 01708302 /; Torem / 01036501 /; K CL TAB; Dafalgan / 00020001 /; Zofran; Nexium; FIG Syrup
Adverse event in receiving Altace (Ramipril)
Reported by a physician from Madagascar on 2007-06-18
Patient:
Adverse reactions / side effects: Acute Pulmonary Oedema, Immunoglobulins Increased, Hepatic Failure, Toxic Epidermal Necrolysis, Transaminases Increased, Renal Failure, Cardiac Failure, Blood Creatinine Increased
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Altace
Dosage: 1 tablet, qd
Indication: Cardiac Failure
Hydrochlorothiazide
Dosage: 1 tablet, qd
Indication: Cardiac Failure
Other drugs received by patient: Amaryl; Fenofibrate
Adverse event in receiving Altace (Ramipril)
Reported by a consumer/non-health professional from Ireland on 2007-05-11
Patient:
Adverse reactions / side effects: Death
Adverse event resulted in: death
Suspect drug(s):
Altace (Ramipril)
Other drugs received by patient: Copaxone / 01410902 /; Insulin
Adverse event in receiving Altace (Ramipril)
Reported by a individual with unspecified qualification from France on 2007-04-18
Patient:
Adverse reactions / side effects: Dyspnoea, Brain Natriuretic Peptide Increased, Troponin I Increased, Pulmonary Oedema
Adverse event resulted in: death
Suspect drug(s):
Altace
Dosage: 2.5 mg, qd
Administration route: Oral
Indication: Hypertension
Start date: 2007-03-05
End date: 2007-03-08
Fludex / 00340101 /
Dosage: 1.5 mg, qd
Administration route: Oral
Indication: Hypertension
Start date: 2007-03-05
End date: 2007-03-08
Triflucan
Dosage: 100 mg, qd
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Start date: 2007-02-05
End date: 2007-03-08
Eupressyl / 00631801 /
Dosage: 30 mg, qd
Administration route: Oral
Indication: Hypertension
Start date: 2007-02-27
End date: 2007-02-27
Eupressyl / 00631801 /
Dosage: 60 mg, qd
Administration route: Oral
Start date: 2007-02-28
End date: 2007-02-28
Eupressyl / 00631801 /
Dosage: 120 mg, qd
Administration route: Oral
Start date: 2007-03-01
End date: 2007-03-03
Eupressyl / 00631801 /
Dosage: 180 mg, qd
Administration route: Oral
Start date: 2007-03-04
End date: 2007-03-04
Sutent
Dosage: 50 mg, qd
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Start date: 2007-02-13
End date: 2007-03-09
Avlocardyl / 00030001 /
Dosage: 40 mg, qd
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Start date: 2007-03-08
End date: 2007-03-08
Other drugs received by patient: Zelitrex / 01269701 /; Duragesic-100; Actiskenan; Lysanxia; Solu-Medrol; Fumafer
Adverse event in receiving Altace (Ramipril)
Reported by a consumer/non-health professional from China on 2007-02-07
Patient:
Adverse reactions / side effects: Death, Hypoproteinaemia, Hypotension, Pollakiuria, Polyuria, Azotaemia
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Altace
Dosage: 2.5 mg, qd
Administration route: Oral
Indication: Cardiac Failure
Furosemide
Dosage: 20 mg, qd
Indication: Cardiac Failure
Adverse event in receiving Altace (Ramipril)
Reported by a consumer/non-health professional from China on 2007-02-07
Patient:
Adverse reactions / side effects: Death, Hypoproteinaemia, Hypotension, Pollakiuria, Polyuria, Azotaemia
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Altace
Dosage: 2.5 mg, qd
Administration route: Oral
Indication: Cardiac Failure
Furosemide
Dosage: 20 mg, qd
Indication: Cardiac Failure
Adverse event in receiving Altace (Ramipril)
Reported by a consumer/non-health professional from France on 2007-02-05
Patient:
Adverse reactions / side effects: Pulmonary Hypertension, Right Ventricular Failure, Dyspnoea, Hypotension, Electromechanical Dissociation, Renal Failure, Cyanosis, Hypoxia, Hypertension, Shock, Venous Occlusion
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Altace
Dosage: 10 mg, qd
Administration route: Oral
Cozaar
Dosage: 1 u, qd
Administration route: Oral
Detensiel / 00802601 /
Dosage: 10 mg, qd
Administration route: Oral
Rapamune
Dosage: 4 mg, qd
Administration route: Oral
End date: 2006-12-09
Lercan
Dosage: 1 u, qd
Administration route: Oral
End date: 2006-12-09
Cellcept
Dosage: 1000 mg, qd
Administration route: Oral
Start date: 2005-07-16
End date: 2006-12-09
Other drugs received by patient: Luteran
Adverse event in receiving Altace (Ramipril)
Reported by a consumer/non-health professional from United States on 2007-01-26
Patient:
Adverse reactions / side effects: Death
Adverse event resulted in: death
Suspect drug(s):
Altace (Ramipril)
|
